商品説明

Antigen activator [Immunosaver] immunosaver-Patented in 7 countries around the world-

-In the past, the activation conditions for cell membranes and nuclei were different, but IS can be activated under the same conditions.

-The treatment method is simple, and it is not necessary to return to room temperature for a long time after heat treatment, and immunostaining can be performed immediately by washing with a buffer solution.

-Good stainability, and some antibodies can increase the dilution rate, leading to cost reduction.

-Very reproducible and stable results can be obtained.

Japanese Patent No. 3797418

U.S. Patent 6960450

European patent 1376096 (Switzerland, Germany, Denmark, United Kingdom, Netherlands)

* Precautions when diluting immunosaver

* Actual immunosaber

* Comparison of primary antibody and activator (specific example of dilution ratio)

* Immunoelectron microscopy (pre-embedding) method

* Comparison of effects by 3 types of activation methods (cyclin D1 antibody)

[ Official homepage of antigen activator"Immuno Saver" ]